Literature DB >> 12066924

Propofol.

John M Abrahams, G Timothy Reiter, Michael A Acker, Grant P Sinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12066924

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


× No keyword cloud information.
  6 in total

1.  The syndrome of irreversible acidosis after prolonged propofol infusion.

Authors:  Monisha A Kumar; Victor C Urrutia; Carole E Thomas; Karine J Abou-Khaled; Robert J Schwartzman
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Propofol Infusion syndrome during refractory status epilepticus in a young adult: successful ECMO resuscitation.

Authors:  Christophe Guitton; Laurence Gabillet; Patrick Latour; Jean-Christophe Rigal; David Boutoille; Ousama Al Habash; Pascal Derkinderen; Cédric Bretonniere; Daniel Villers
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

Review 3.  [Propofol infusion syndrome].

Authors:  J Motsch; J Roggenbach
Journal:  Anaesthesist       Date:  2004-10       Impact factor: 1.041

4.  Vasopressors and propofol infusion syndrome in severe head trauma.

Authors:  Heidi Smith; Grant Sinson; Panayiotis Varelas
Journal:  Neurocrit Care       Date:  2008-12-03       Impact factor: 3.210

5.  Propofol infusion syndrome resuscitation with extracorporeal life support: a case report and review of the literature.

Authors:  Michael Mayette; Jeremy Gonda; Joe L Hsu; Frederick G Mihm
Journal:  Ann Intensive Care       Date:  2013-09-23       Impact factor: 6.925

6.  Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study.

Authors:  Russel J Roberts; Jeffrey F Barletta; Jeffrey J Fong; Greg Schumaker; Philip J Kuper; Stella Papadopoulos; Dinesh Yogaratnam; Elise Kendall; Renee Xamplas; Anthony T Gerlach; Paul M Szumita; Kevin E Anger; Paul A Arpino; Stacey A Voils; Philip Grgurich; Robin Ruthazer; John W Devlin
Journal:  Crit Care       Date:  2009-10-29       Impact factor: 9.097
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.